Sort
82,697 grants matching “vaccine development”
Establishment and operation of a Vaccine Pilot Plant
$33,687,835Frank Arnold · National Institute Of Allergy And Infectious Diseases · ZIB · FY2018 · AI
AIDS Clinical Trials Group Network
$33,583,843Daniel R Kuritzkes · Brigham And Women'S Hospital · UM1 · FY2012 · AI
Consortium for HIV/AIDS Vaccine Development
$33,346,203Dennis R. Burton · Scripps Research Institute, The · UM1 · FY2020 · AI
NICHD INTERNATIONAL & DOMESTIC PEDIATRIC & MATERNAL HIV STUDIES DATA COORDINATING CENTER
$33,256,095Barbara Driver · Westat, Inc. · N01 · FY2015 · HD
NICHD INTERNATIONAL & DOMESTIC PEDIATRIC & MATERNAL HIV STUDIES DATA COORDINATING CENTER
$33,197,048Barbara Driver · Westat, Inc. · N01 · FY2016 · HD
The UCI Vaccines for Pandemic Preparedness Center (VPPC)
$33,116,067Philip Louis Felgner · University Of California-Irvine · U19 · FY2024 · AI
HIV Vaccine Trials Network Laboratory Center
$33,072,609Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · AI
Consortium for HIV/AIDS Vaccine Development
$32,853,126Dennis R. Burton · Scripps Research Institute, The · UM1 · FY2021 · AI
DEVELOPING A HER3 VACCINE TO PREVENT RESISTANCE TO ENDOCRINE THERAPY
$32,713,681Duke University · · FY2012 · Department of the Army
Establishment and operation of a Vaccine Pilot Plant
$32,433,046Frank Arnold · National Institute Of Allergy And Infectious Diseases · ZIB · FY2019 · AI
Leadership Group for a Global HIV Vaccine Clinical Trials Network
$32,353,045Lawrence Corey · Fred Hutchinson Cancer Research Center · UM1 · FY2012 · AI
SDMC: HIV Vaccine Trials Network
$31,992,488Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2024 · AI
Influenza Vaccine Research and Development
$31,820,000Masaru Kanekiyo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Establishment of a Vaccine Pilot Plant
$31,080,346Frank Arnold · National Institute Of Allergy And Infectious Diseases · ZIB · FY2017 · AI
NICHD INTERNATIONAL & DOMESTIC PEDIATRIC & MATERNAL HIV STUDIES COORDINATING CTR
$30,919,012Carol Nesel · Westat, Inc. · N01 · FY2013 · HD
HIV Vaccine Trials Network Laboratory Center
$30,868,345Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery
$30,829,843Barton F Haynes · Duke University · UM1 · FY2016 · AI
Induction of protective antibodies for HIV vaccine development
$30,401,371Barton F Haynes · Duke University · UM1 · FY2023 · AI
HIV Vaccines Clinical Trials Network Leadership and Operations Center
$30,396,659Lawrence Corey · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
HIV Vaccine Trials Network Laboratory Center
$30,362,486Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
Ebola Virus and Other Emerging & Re-emerging Infectious Diseases
$30,337,006Beth Baseler · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA
LOC: HIV Vaccine Trials Network
$30,221,723Lawrence Corey · Fred Hutchinson Cancer Research Center · UM1 · FY2016 · AI
Consortium for HIV/AIDS Vaccine Development
$30,204,757Dennis R. Burton · Scripps Research Institute, The · UM1 · FY2023 · AI
HVTN 405/HPTN 1901 Characterizing SARS-CoV-2-specific immunity in convalescent individuals: LC
$29,952,323Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2020 · AI
Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery
$29,907,331Barton F Haynes · Duke University · UM1 · FY2014 · AI